Q&A with Dr. Sofija Jovic

February 7, 2019

Increasingly, sponsors are turning to experts who have “been there, done that” to help them develop protocols for their CNS trials. In this wide-ranging interview, Sofija Jovic, PhD, MBA, of WCG MedAvanteProPhase, explains why this is the case. She also discusses, among other topics, how clinical trial metrics haven’t always kept pace with scientific innovation.

Previous Flipbook
Q&A with CNS Expert, Dr. Philip Scheltens
Q&A with CNS Expert, Dr. Philip Scheltens

Philip Scheltens, MD, PhD, a member of WCG’s Scientific Leadership Team, shared his insights during a recen...

Next Flipbook
Q&A with CNS Expert, Dr. Leo Verhagen Metman
Q&A with CNS Expert, Dr. Leo Verhagen Metman

Leo Verhagen Metman, a member of WCG’s Scientific Leadership Team, shared his insights during a recent conv...